Most smaller pharmaceutical companies still sweating over 2012 business plan

A majority of small- and medium-sized Korean drug firms are still struggling to finalize their business plans for the new year, according to pharmaceutical business sources.

The government’s large drug price cut plan has led many companies to say they have no plans to jump into a new business next year, raising fears that the average of their operating profit will dip by 20 percent next yea...